Do mergers and acquisitions create shareholder wealth in the pharmaceutical industry?-Reference-Cited by-同舟云学术

Do mergers and acquisitions create shareholder wealth in the pharmaceutical industry?

Published:2007-04-10 Issue:1 Volume:1 Page:58-78
ISSN:1750-6123
Container-title:International Journal of Pharmaceutical and Healthcare Marketing
language:en
Short-container-title:Intl J of Pharm & Health Mrkt

Author:

Hassan Mahmud,Patro Dilip K.,Tuckman Howard,Wang Xiaoli

Publisher

Emerald

Subject

Marketing,Health Policy

Reference25 articles.

1. The Post-Merger Performance of Acquiring Firms: A Re-examination of an Anomaly

2. New Evidence and Perspectives on Mergers

3. André, P., Kooli, M. and L'Her, J. (2004), “The long‐run performance of mergers and acquisitions: evidence from the Canadian Stock Market”, Financial Management, Vol. 33, pp. 27‐43.

4. The gains to bidding firms from merger

5. The U.S. Pharmaceutical Industry: Why Major Growth In Times Of Cost Containment?

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To merge or not to merge? The impact of mergers and acquisitions on corporate success in the pharmaceutical industry;Managerial and Decision Economics;2024-02-12

2. The Effect of Mergers and Acquisitions on Efficiency: Evidence from the Pharmaceutical Industry;International Symposium on Engineering and Business Administration;2023-08-30

3. The impact of mergers and acquisitions on shareholders' value: an empirical study of pharmaceutical companies;Managerial Finance;2023-01-12

4. Cross-Border Acquisitions and Shareholders’ Wealth: The Case of the Indian Pharmaceutical Sector;Journal of Risk and Financial Management;2022-09-27

5. The effect of technology driven mergers and acquisitions on firm performance in the U.S. textile industry;The Journal of The Textile Institute;2022-09-21